Gabriela Studer
Consolidation cetuximab after concurrent triplet radiochemotherapy+cetuximab in patients with advanced head and neck cancer: A randomized phase II study.
Riesterer O, Pruschy M, Bender S, Sharma A, Bogowicz M, Tanadini-Lang S, Stieb S, Bertogg K, Weber S, Ikenberg K, Huber G, Schmid S, Bredell M, Veit-Haibach P, Rordorf T, Held U, Glanzmann C, Studer G. Consolidation cetuximab after concurrent triplet radiochemotherapy+cetuximab in patients with advanced head and neck cancer: A randomized phase II study. Radiother Oncol 2020; 150:62-69.
Jun 12, 2020Consolidation cetuximab after concurrent triplet radiochemotherapy+cetuximab in patients with advanced head and neck cancer: A randomized phase II study.
Jun 12, 2020Radiother Oncol 2020; 150:62-69
Riesterer Oliver, Pruschy Martin, Bender Sabine, Sharma Ashish, Bogowicz Marta, Tanadini-Lang Stephanie, Stieb Sonja, Bertogg Kaja, Weber Sandra, Ikenberg Kristian, Huber Gerhard, Schmid Stephan, Bredell Marius, Veit-Haibach Patrick, Rordorf Tamara, Held Ulrike, Glanzmann Christoph, Studer Gabriela
Evaluation of 18F-FDG PET/CT as an early imaging biomarker for response monitoring after radiochemotherapy using cetuximab in head and heck squamous cell carcinoma
de Galiza Barbosa F, Stolzmann P, Huellner M, Huber G, Pruschy M, Studer G, Stieb S, Tanadini-Lang S, Riesterer O, Veit-Haibach P. Evaluation of 18F-FDG PET/CT as an early imaging biomarker for response monitoring after radiochemotherapy using cetuximab in head and heck squamous cell carcinoma. Head & neck 2019; 42:163-170.
Nov 9, 2019Evaluation of 18F-FDG PET/CT as an early imaging biomarker for response monitoring after radiochemotherapy using cetuximab in head and heck squamous cell carcinoma
Nov 9, 2019Head & neck 2019; 42:163-170
de Galiza Barbosa Felipe, Stolzmann Paul, Huellner Martin W, Huber Gerhard, Pruschy Martin, Studer Gabriela, Stieb Sonja, Tanadini-Lang Stephanie, Riesterer Oliver, Veit-Haibach Patrick
Influencing Factors on Radiotherapy Outcome in Stage I-II Glottic Larynx Cancer-A Multicenter Study
Elicin O, Giger R, Spielmann T, Prestwich R, Riesterer O, Kaydıhan N, Shelan M, Guckenberger M, Ozsahin M, Anschuetz L, Adam L, Henke G, Studer G, Zimmermann F, Caparrotti F, Aebersold D, Oehler C, Ermiş E, Şen M. Influencing Factors on Radiotherapy Outcome in Stage I-II Glottic Larynx Cancer-A Multicenter Study. Front Oncol 2019; 9:932.
Sep 20, 2019Influencing Factors on Radiotherapy Outcome in Stage I-II Glottic Larynx Cancer-A Multicenter Study
Sep 20, 2019Front Oncol 2019; 9:932
Elicin Olgun, Giger Roland, Spielmann Thierry, Prestwich Robin J D, Riesterer Oliver, Kaydıhan Nuri, Shelan Mohamed, Guckenberger Matthias, Ozsahin Mahmut, Anschuetz Lukas, Adam Lukas, Henke Guido, Studer Gabriela, Zimmermann Frank, Caparrotti Francesca, Aebersold Daniel M, Oehler Christoph, Ermiş Ekin, Şen Mehmet
[Modern Treatment Concepts in Radiation Oncology]
Plasswilm L, Studer G, Aebersold D, Zwahlen D. [Modern Treatment Concepts in Radiation Oncology]. Ther Umsch 2019; 76:209-218.
Sep 1, 2019[Modern Treatment Concepts in Radiation Oncology]
Sep 1, 2019Ther Umsch 2019; 76:209-218
Plasswilm Ludwig, Studer Gabriela, Aebersold Daniel M, Zwahlen Daniel R
Expression of CK19 is an independent predictor of negative outcome for patients with squamous cell carcinoma of the tongue.
Ernst J, Ikenberg K, Apel B, Schumann D, Huber G, Studer G, Rordorf T, Riesterer O, Rössle M, Korol D, Bredell M. Expression of CK19 is an independent predictor of negative outcome for patients with squamous cell carcinoma of the tongue. Oncotarget 2016; 7:76151-76158.
Nov 15, 2016Expression of CK19 is an independent predictor of negative outcome for patients with squamous cell carcinoma of the tongue.
Nov 15, 2016Oncotarget 2016; 7:76151-76158
Ernst Jutta, Ikenberg Kristian, Apel Barbara, Schumann Desiree M, Huber Gerhard, Studer Gabriela, Rordorf Tamara, Riesterer Oliver, Rössle Matthias, Korol Dimitri, Bredell Marius
IMRT/VMAT for malignancies in the head-and-neck region : Outcome in patients aged 80.
Brown M, Glanzmann C, Huber G, Bredell M, Rordorf T, Studer G. IMRT/VMAT for malignancies in the head-and-neck region : Outcome in patients aged 80. Strahlenther Onkol 2016; 192:526-36.
Jun 15, 2016IMRT/VMAT for malignancies in the head-and-neck region : Outcome in patients aged 80.
Jun 15, 2016Strahlenther Onkol 2016; 192:526-36
Brown Michelle L, Glanzmann Christoph, Huber Gerhard, Bredell Marius, Rordorf Tamara, Studer Gabriela
Perineural Invasion in Squamous Cell Carcinoma of the Oral Cavity: Histology, Tumor Stage, and Outcome
Laske R, Scholz I, Ikenberg K, Meerwein C, Vital D, Studer G, Rössle M, Huber G. Perineural Invasion in Squamous Cell Carcinoma of the Oral Cavity: Histology, Tumor Stage, and Outcome. Laryngoscope Investig Otolaryngol 2016; 1:13-18.
Jan 14, 2016Perineural Invasion in Squamous Cell Carcinoma of the Oral Cavity: Histology, Tumor Stage, and Outcome
Jan 14, 2016Laryngoscope Investig Otolaryngol 2016; 1:13-18
Laske Roman D, Scholz Irene, Ikenberg Kristian, Meerwein Christian, Vital Domenic G, Studer Gabriela, Rössle Matthias, Huber Gerhard
Combined PET/CT-perfusion in patients with head and neck cancers might predict failure after radio-chemotherapy: a proof of concept study
Pietsch C, de Galiza Barbosa F, Hüllner M, Schmid D, Haerle S, Huber G, Studer G, Hany T, Veit-Haibach P. Combined PET/CT-perfusion in patients with head and neck cancers might predict failure after radio-chemotherapy: a proof of concept study. BMC Med Imaging 2015; 15:60.
Dec 29, 2015Combined PET/CT-perfusion in patients with head and neck cancers might predict failure after radio-chemotherapy: a proof of concept study
Dec 29, 2015BMC Med Imaging 2015; 15:60
Pietsch Carsten, de Galiza Barbosa Felipe, Hüllner Martin W, Schmid Daniel T, Haerle Stephan K, Huber Gerhard, Studer Gabriela, Hany Thomas F, Veit-Haibach Patrick
Does airway intervention before primary nonsurgical therapy for T3/T4 laryngeal squamous cell carcinoma impact on oncological or functional outcomes?
Schariatzadeh R, Pezier T, Studer G, Schmid S, Huber G. Does airway intervention before primary nonsurgical therapy for T3/T4 laryngeal squamous cell carcinoma impact on oncological or functional outcomes?. Swiss Med Wkly 2015; 145:w14213.
Nov 23, 2015Does airway intervention before primary nonsurgical therapy for T3/T4 laryngeal squamous cell carcinoma impact on oncological or functional outcomes?
Nov 23, 2015Swiss Med Wkly 2015; 145:w14213
Schariatzadeh René, Pezier Thomas F, Studer Gabriela, Schmid Stephan, Huber Gerhard
Less may be more: nodal treatment in neck positive head neck cancer patients
Studer G, Huber G, Holz E, Glanzmann C. Less may be more: nodal treatment in neck positive head neck cancer patients. Eur Arch Otorhinolaryngol 2015; 273:1549-56.
Apr 29, 2015Less may be more: nodal treatment in neck positive head neck cancer patients
Apr 29, 2015Eur Arch Otorhinolaryngol 2015; 273:1549-56
Studer Gabriela, Huber Gerhard, Holz Edna, Glanzmann Christoph
Outcome in squamous cell carcinoma of the nasal vestibule: a single center experience
Vital D, Morand G, Huber G, Studer G, Holzmann D. Outcome in squamous cell carcinoma of the nasal vestibule: a single center experience. Head & neck 2014; 37:46-51.
Apr 15, 2014Outcome in squamous cell carcinoma of the nasal vestibule: a single center experience
Apr 15, 2014Head & neck 2014; 37:46-51
Vital Domenic, Morand Grégoire, Huber Gerhard, Studer Gabriela, Holzmann David
Late term tolerance in head neck cancer patients irradiated in the IMRT era.
Studer G, Linsenmeier C, Riesterer O, Najafi Y, Brown M, Yousefi B, Bredell M, Huber G, Schmid S, Studer S, Zwahlen R, Rordorf T, Glanzmann C. Late term tolerance in head neck cancer patients irradiated in the IMRT era. Radiat Oncol 2013; 8:259.
Nov 5, 2013Late term tolerance in head neck cancer patients irradiated in the IMRT era.
Nov 5, 2013Radiat Oncol 2013; 8:259
Studer Gabriela, Linsenmeier Claudia, Riesterer Oliver, Najafi Yousef, Brown Michelle L, Yousefi Bita, Bredell Marius, Huber Gerhard, Schmid Stephan, Studer Stephan, Zwahlen Roger A, Rordorf Tamara, Glanzmann Christoph
Impact of p16, p53, smoking, and alcohol on survival in patients with oropharyngeal squamous cell carcinoma treated with primary intensity-modulated chemoradiation
Broglie Däppen M, Soltermann A, Rohrbach D, Haile S, Pawlita M, Studer G, Huber G, Moch H, Stöckli S. Impact of p16, p53, smoking, and alcohol on survival in patients with oropharyngeal squamous cell carcinoma treated with primary intensity-modulated chemoradiation. Head & neck 2013; 35:1698-706.
Mar 18, 2013Impact of p16, p53, smoking, and alcohol on survival in patients with oropharyngeal squamous cell carcinoma treated with primary intensity-modulated chemoradiation
Mar 18, 2013Head & neck 2013; 35:1698-706
Broglie Däppen Martina, Soltermann Alex, Rohrbach David, Haile Sarah R, Pawlita Michael, Studer Gabriela, Huber Gerard F, Moch Holger, Stöckli Sandro
Follow up after IMRT in oral cavity cancer: update.
Studer G, Brown M, Bredell M, Graetz K, Huber G, Linsenmeier C, Najafi Y, Riesterer O, Rordorf T, Schmid S, Glanzmann C. Follow up after IMRT in oral cavity cancer: update. Radiat Oncol 2012; 7:84.
Jun 11, 2012Follow up after IMRT in oral cavity cancer: update.
Jun 11, 2012Radiat Oncol 2012; 7:84
Studer Gabriela, Brown Michelle L, Bredell Marius, Graetz Klaus W, Huber Gerhard, Linsenmeier Claudia, Najafi Yousef, Riesterer Oliver, Rordorf Tamara, Schmid Stephan, Glanzmann Christoph
Impact of tumor volume and systemic therapy on outcome in patients undergoing IMRT for large volume head neck cancer.
Studer G, Rordorf T, Glanzmann C. Impact of tumor volume and systemic therapy on outcome in patients undergoing IMRT for large volume head neck cancer. Radiat Oncol 2011; 6:120.
Sep 22, 2011Impact of tumor volume and systemic therapy on outcome in patients undergoing IMRT for large volume head neck cancer.
Sep 22, 2011Radiat Oncol 2011; 6:120
Studer Gabriela, Rordorf Tamara, Glanzmann Christoph
Down regulation of E-Cadherin (ECAD) - a predictor for occult metastatic disease in sentinel node biopsy of early squamous cell carcinomas of the oral cavity and oropharynx
Huber G, Züllig L, Soltermann A, Roessle M, Haerle S, Studer G, Jochum W, Moch H, Stöckli S. Down regulation of E-Cadherin (ECAD) - a predictor for occult metastatic disease in sentinel node biopsy of early squamous cell carcinomas of the oral cavity and oropharynx. BMC cancer 2011; 11:217:1-8.
Jun 3, 2011Down regulation of E-Cadherin (ECAD) - a predictor for occult metastatic disease in sentinel node biopsy of early squamous cell carcinomas of the oral cavity and oropharynx
Jun 3, 2011BMC cancer 2011; 11:217:1-8
Huber Gerhard F, Züllig Lena, Soltermann Alex, Roessle Matthias, Haerle Stephan K, Studer Gabriela, Jochum Wolfram, Moch Holger, Stöckli Sandro
Intensitätsmodulierte Radiotherapie beim Oropharynxkarzinom
Broglie Däppen M, Huber G, Stöckli S, Studer G. Intensitätsmodulierte Radiotherapie beim Oropharynxkarzinom. Schweiz Med Forum 2010; Suppl. 54:114-116.
Oct 27, 2010Intensitätsmodulierte Radiotherapie beim Oropharynxkarzinom
Oct 27, 2010Schweiz Med Forum 2010; Suppl. 54:114-116
Broglie Däppen Martina, Huber Gerhard F, Stöckli Sandro, Studer Gabriela
Salvage treatment for recurrent oropharyngeal squamous cell carcinoma
Röösli C, Studer G, Stöckli S. Salvage treatment for recurrent oropharyngeal squamous cell carcinoma. Head & neck 2010; 32:989-96.
Aug 1, 2010Salvage treatment for recurrent oropharyngeal squamous cell carcinoma
Aug 1, 2010Head & neck 2010; 32:989-96
Röösli Christof, Studer Gabriela, Stöckli Sandro
Outcome of patients after treatment for a squamous cell carcinoma of the oropharynx
Röösli C, Tschudi D, Studer G, Braun J, Stöckli S. Outcome of patients after treatment for a squamous cell carcinoma of the oropharynx. The Laryngoscope 2009; 119:534-40.
Mar 1, 2009Outcome of patients after treatment for a squamous cell carcinoma of the oropharynx
Mar 1, 2009The Laryngoscope 2009; 119:534-40
Röösli Christof, Tschudi Dominique C, Studer Gabriela, Braun Julia, Stöckli Sandro
Postoperative IMRT in head and neck cancer
Studer G, Furrer K, Davis B, Stöckli S, Zwahlen R, Luetolf U, Glanzmann C. Postoperative IMRT in head and neck cancer. Radiat Oncol 2006; 1:40.
Oct 19, 2006Postoperative IMRT in head and neck cancer
Oct 19, 2006Radiat Oncol 2006; 1:40
Studer Gabriela, Furrer Katrin, Davis Bernard J, Stöckli Sandro, Zwahlen Roger A, Luetolf Urs M, Glanzmann Christoph